InsidersTradesSigma
申报总数
公司
▲ 买入（0 笔）
▼ 卖出（1 笔）
内部人交易记录
高级管理人员已披露买入
0
已披露卖出
1
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Discover the full record of transactions filed by Jung Cassie, 首席运营官. Insider active across 1 company, notably Aquestive Therapeutics, Inc.. Cumulatively, 10 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €205. History available since 9 March 2023. The latest transaction was filed on 3 September 2026 (X). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Jung Cassie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
4,587 股@ US$0.96Common StockSEC:0001214659-26-011475:0
80,000 股0Common StockSEC:0001214659-26-003141:0
25,000 股@ US$3.10270.014% mcap50.0% 占其流量Common StockSEC:0001214659-25-015048:0
25,000 股@ US$3.1528.8% 占其流量Common StockSEC:0001214659-25-013493:0
80,000 股0Common StockSEC:0001214659-25-004227:0
44 股@ US$4.8650.1% 占其流量Common StockSEC:0001214659-24-019685:0
14,120 股@ US$4.8827.0% 占其流量Common StockSEC:0001214659-24-017008:0
8,300 股@ US$4.8815.9% 占其流量Common StockSEC:0001214659-24-004390:0
1,365 股0Common StockSEC:0001214659-24-004304:0
110,000 股0Common StockSEC:0001214659-23-003693:0
10 条申报中的 10 条
About Jung Cassie
Jung Cassie is Chief Operating Officer at Aquestive Therapeutics, Inc. Across 9 filings in total, the 9 sampled filings run from 2023-03-09 to 2026-03-11, with EUR 0 of buys and EUR 205 of sells, and the most frequent transaction nature is Attribution.
